International Stem Cell Corporation
ISCO
$0.18
$0.001.50%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -9.03% | -3.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.03% | -3.19% | |||
| Cost of Revenue | 1.72% | 13.05% | |||
| Gross Profit | -17.56% | -13.09% | |||
| SG&A Expenses | 69.88% | -10.24% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.48% | -0.22% | |||
| Operating Income | -432.98% | -43.71% | |||
| Income Before Tax | -710.53% | -55.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -710.53% | -55.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -710.53% | -55.81% | |||
| EBIT | -432.98% | -43.71% | |||
| EBITDA | -272.67% | -32.13% | |||
| EPS Basic | -1,308.33% | -57.14% | |||
| Normalized Basic EPS | -704.44% | -55.45% | |||
| EPS Diluted | -1,308.33% | -57.14% | |||
| Normalized Diluted EPS | -718.18% | -56.44% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -1.99% | 2.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||